Stock LAVI LAVIPHARM S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Lavipharm S.A.

Equities

LAVI

GRS246003008

Market Closed - Athens S.E.
Other stock markets
 15:15:19 30/05/2024 BST 		5-day change 1st Jan Change
0.924 EUR +0.33% Intraday chart for Lavipharm S.A. -4.15% +16.08%
02-28 Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi. CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. LAVI Stock
  4. News Lavipharm S.A.
  5. Official Publications